BRIEF-Wave Life Sciences Plans To Have Five Galnac-RNA Editing Or GalNAc-siRNA Programs In Clinic By 2026
Reuters
Oct 31, 2024
Oct 30 (Reuters) - WAVE Life Sciences Ltd :
* WAVE LIFE SCIENCES LTD: PLANS TO HAVE FIVE GALNAC-RNA EDITING OR GALNAC-SIRNA PROGRAMS IN CLINIC BY 2026
* WAVE LIFE SCIENCES LTD: WVE-007 (INHBE GALNAC-SIRNA FOR OBESITY) IS ON TRACK TO INITIATE A CLINICAL TRIAL IN 1Q 2025
* WAVE LIFE SCIENCES: NEW PRECLINICAL DATA IN DIET INDUCED OBESE (DIO) MICE DEMONSTRATE POTENTIAL OF WVE-007 TO BE USED ACROSS TREATMENT CONTINUUM
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.